TNF Pharma - Kapitalisasi pasar TNFA

TNF Pharmaceuticals (TNFA) relies on patent protection for its anti-inflammatory formulas to overcome the challenges of costly development and legal risks. Current capitalization stands at 0.01, while the price visualization available on the GURU.Markets page accompanies an analysis of the high-cost metabolic pathology pipeline. The company's growth is based on partnerships with biotech centers, which enhances its attractiveness for potential mergers.

TNF Pharmaceuticals Inc. - Kapitalisasi pasar TNFA (periode 25.07.2024 - 25.09.2025)

Rincian metrik komprehensif lan analitis tnfpharma.com (TNFA)

Indikator keuangan lan pasar perusahaan TNF Pharmaceuticals (TNFA):
Bagan rega TNF Pharmaceuticals, Inc.|TNFA - Prakiraan gabungan firma investasi|Kapitalisasi pasar TNF Pharmaceuticals, Inc.
Analisis fundamental perusahaan:TNFA (TNF Pharma)

Professional asset selection begins with an analysis of market value to assess business resilience. This indicator aggregates all outstanding shares at the current price, defining 0.01 as the final scale of capital. By analyzing the company's market value, an investor separates speculative noise from actual capitalization. For TNF Pharmaceuticals (TNFA), this metric reflects market confidence in clinical trials. The issuer's stable balance sheet confirms the validity of the current valuation.

Pesaing wigati

Nilai pasar Haleon HLN|KVUE: Kapitalisasi pasar|Verona Pharma Corp - Kapitalisasi pasar|Biji pasar MENS|LGND: Kapitalisasi pasar|amneal.com (AMRX) - Kapitalisasi pasar|Nilai pasar Perrigo|Alvotech S.A. - Biji pasar|Kapitalisasi pasar LQDA|GLPG (Galapagos Corp) - Nilai pasar|Kapitalisasi pasar ANIP (ANI Pharmaceuticals)|Kapitalisasi pasar mannkindcorp.com MNKD|AMPH - Nilai pasar|Nilai pasar PCRX (Pacira Pharmaceuticals)|ARS Pharma (SPRY) - Nilai pasar|Biji pasar Theravance Corp|AQST (Aquestive Therapeutics) - Kapitalisasi pasar|Kapitalisasi pasar scPharma|Biji pasar TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharma) - Nilai pasar|Nilai pasar China SXT Pharmaceuticals, Inc. SXTC|Eupraxia Pharmaceuticals, Inc. (EPRX) - Nilai pasar|BHST: Biji pasar|invizyne.com - Nilai pasar|ORMP: Kapitalisasi pasar|Entera Bio - Nilai pasar|HYFT (MindWalk) - Kapitalisasi pasar|Nilai pasar ABVC BioPharma, Inc ABVC|Nilai pasar Cumberland Pharmaceuticals (CPIX)|QNTM (quantumbiopharma.com) - Nilai pasar|FibroGen - Biji pasar|Nilai pasar TELO (Telomir Pharmaceuticals Inc)|RANI - Nilai pasar|SNYR (Synergy CHC Corp) - Kapitalisasi pasar|RLYB: Kapitalisasi pasar|Biji pasar LEXX (Lexaria Bioscience Corp.)|Biji pasar PULM|PTHL: Nilai pasar|Nilai pasar Aptorum Group Limited (APM)|LYRA: Biji pasar|Kapitalisasi pasar IBO (Impact BioMedical)|Nilai pasar YCBD|PainReform - Kapitalisasi pasar|CYTO - Kapitalisasi pasar|Lipella (LIPO) - Nilai pasar|OptiNose Corp - Nilai pasar|Nilai pasar Pieris Pharmaceuticals|Biji pasar procapsgroup.com (PROC)|Kapitalisasi pasar PTPI|Kapitalisasi pasar Qilian International Holding Group (QLI)|Kapitalisasi pasar SLRN (ACELYRIN, Inc.)|TFFP - Biji pasar